Introduction Nausea is the number one reason people consider stopping their GLP1 medication, and it is the most commonly reported side effect across semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)
These symptoms are often misattributed to overtraining, when in reality they may stem from an underlying nutritional imbalance
Its pulsatile, released in waves, with peaks and troughs that tend to crest at night
adults had taken GLP-1 drugs, and 6% were currently taking them
STEP 1 Trial The STEP 1 trial included 1,961 adults who were either overweight or had obesity
Clinical research on semaglutide, the active ingredient in Ozempic and Wegovy, found it did not lower the amount of hormone that reached the bloodstream from a combined birth control pill (Kapitza et al., Journal of Clinical Pharmacology)